Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ip

Showing results (491-500 of 517) with videos related to

Pageof 52
Sort By:
Nature Medicine|May 29, 2020
Author Correction: Respiratory virus shedding in exhaled breath and efficacy of face masksNancy H L Leung, Daniel K W Chu, Eunice Y C Shiu, et al.
Nature Medicine|May 7, 2020
Respiratory virus shedding in exhaled breath and efficacy of face masksNancy H L Leung, Daniel K W Chu, Eunice Y C Shiu, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 16, 2007
Features discriminating SARS from other severe viral respiratory tract infectionsT H Rainer, N Lee, M Ip, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2025
Enhanced Influenza Vaccines Extend A(H3N2) Antibody Reactivity in Older Adults but Prior Vaccination Effects PersistAnnette Fox, Stephany Sánchez-Ovando, Louise Carolan, et al.
BMJ (Clinical Research Ed.)|June 27, 2013
Detection of mild to moderate influenza A/H7N9 infection by China's national sentinel surveillance system for influenza-like illness: case seriesDennis K M Ip, Qiaohong Liao, Peng Wu, et al.
The Journal of Infectious Diseases|September 15, 2022
Slow Waning of Antibodies Following BNT162b2 as a Third Dose in Adults Who Had Previously Received 2 Doses of Inactivated VaccineBenjamin J Cowling, Samuel M S Cheng, Mario Martín-Sánchez, et al.
The Journal of Infectious Diseases|November 11, 2023
Influenza A(H3N2) Antibody Responses to Standard-Dose Versus Enhanced Influenza Vaccine Immunogenicity in Older Adults and Prior Season's Vaccine StatusShuyi Zhong, Tiffany W Y Ng, Danuta M Skowronski, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
Preliminary findings from the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: a Randomized Controlled TrialBenjamin J Cowling, Sook-San Wong, Jefferson J S Santos, et al.
The Lancet. Infectious Diseases|April 20, 2026
Measuring population immunity against influenza using individual antibody titres: a multicountry, retrospective observational studyWeijia Xiong, Xiaotong Huang, Tran Thi Nhu Thao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2017
Immune Responses to Twice-Annual Influenza Vaccination in Older Adults in Hong KongYat Hung Tam, Sophie A Valkenburg, Ranawaka A P M Perera, et al.
Pageof 52

Showing results (491-500 of 517) with videos related to

Sort By:
Pageof 52
Nature Medicine|May 29, 2020
Author Correction: Respiratory virus shedding in exhaled breath and efficacy of face masksNancy H L Leung, Daniel K W Chu, Eunice Y C Shiu, et al.
Nature Medicine|May 7, 2020
Respiratory virus shedding in exhaled breath and efficacy of face masksNancy H L Leung, Daniel K W Chu, Eunice Y C Shiu, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 16, 2007
Features discriminating SARS from other severe viral respiratory tract infectionsT H Rainer, N Lee, M Ip, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2025
Enhanced Influenza Vaccines Extend A(H3N2) Antibody Reactivity in Older Adults but Prior Vaccination Effects PersistAnnette Fox, Stephany Sánchez-Ovando, Louise Carolan, et al.
BMJ (Clinical Research Ed.)|June 27, 2013
Detection of mild to moderate influenza A/H7N9 infection by China's national sentinel surveillance system for influenza-like illness: case seriesDennis K M Ip, Qiaohong Liao, Peng Wu, et al.
The Journal of Infectious Diseases|September 15, 2022
Slow Waning of Antibodies Following BNT162b2 as a Third Dose in Adults Who Had Previously Received 2 Doses of Inactivated VaccineBenjamin J Cowling, Samuel M S Cheng, Mario Martín-Sánchez, et al.
The Journal of Infectious Diseases|November 11, 2023
Influenza A(H3N2) Antibody Responses to Standard-Dose Versus Enhanced Influenza Vaccine Immunogenicity in Older Adults and Prior Season's Vaccine StatusShuyi Zhong, Tiffany W Y Ng, Danuta M Skowronski, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
Preliminary findings from the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: a Randomized Controlled TrialBenjamin J Cowling, Sook-San Wong, Jefferson J S Santos, et al.
The Lancet. Infectious Diseases|April 20, 2026
Measuring population immunity against influenza using individual antibody titres: a multicountry, retrospective observational studyWeijia Xiong, Xiaotong Huang, Tran Thi Nhu Thao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2017
Immune Responses to Twice-Annual Influenza Vaccination in Older Adults in Hong KongYat Hung Tam, Sophie A Valkenburg, Ranawaka A P M Perera, et al.
Pageof 52